Publications

• Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial.

  (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF.) Pract Radiat Oncol. 2021 Nov-Dec;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021

• Pain management following robotic-assisted radical prostatectomy: transitioning to an opioid free regimen.

  (Prebay ZJ, Medairos R, Landowski T, Everett RG, Doolittle J, Kansal JK, Jacobsohn K, Johnson SC.) J Robot Surg. 2021 Dec;15(6):923-928 PMID: 33495942 01/27/2021

• Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort.

  (Taylor J, Becher E, Wysock JS, Lenis AT, Litwin MS, Jipp J, Langenstroer P, Johnson S, Bjurlin MA, Tan HJ, Lane BR, Huang WC.) Eur Urol Focus. 2021 Nov;7(6):1403-1408 PMID: 32682794 SCOPUS ID: 2-s2.0-85087965545 07/20/2020

• The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?

  (Lemke E, Sahasrabudhe D, Guancial E, Bylow K, Johnson S, Messing E, Kilari D.) Clin Genitourin Cancer. 2020 08;18(4):e478-e483 PMID: 32085986 SCOPUS ID: 2-s2.0-85079745146 02/23/2020

• AUTHOR REPLY.

  (Berger GK, Medairos R, Johnson SC.) Urology. 2020 03;137:24-25 PMID: 32115069 03/03/2020

• Factors Influencing Patient Selection of Urologists.

  (Berger GK, Medairos R, Regala P, Jacobsohn K, Langenstroer P, See WA, Johnson SC.) Urology. 2020 03;137:19-25 PMID: 31809771 SCOPUS ID: 2-s2.0-85077649742 12/07/2019

• Resolution of Abdominal Pain After Coil Embolization of Varicocele with Robotic Resection of Gonadal Vein.

  (Doolittle J, Maniar V, Dietrich P, Sandlow J, Johnson S, Kansal J.) J Endourol Case Rep. 2020;6(4):533-535 PMID: 33457722 PMCID: PMC7803188 01/19/2021

• Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.

  (Doolittle J, Piotrowski J, Zuk K, Jacobsohn K, Langenstroer P, See W, Johnson S.) Urology. 2019 Oct;132:136-142 PMID: 31279691 SCOPUS ID: 2-s2.0-85072718431 07/08/2019

• Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.

  (Johnson SC, Smith ZL, Nottingham C, Schwen ZR, Thomas S, Fishman EK, Lee NJ, Pierorazio PM, Eggener SE.) Urology. 2019 01;123:186-190 PMID: 30179635 09/05/2018

• Primary angiosarcoma of the testis with retroperitoneal metastasis.

  (Piotrowski JT, Schaefer MB, Charlson JA, Iczkowski KA, Johnson SC.) Urol Case Rep. 2018 Nov;21:116-118 PMID: 30294549 PMCID: PMC6168964 10/09/2018

• Perioperative and long-term outcomes after radical cystectomy in hemodialysis patients.

  (Johnson SC, Smith ZL, Golan S, Rodriguez JF 3rd, Pearce SM, Smith ND, Steinberg GD.) Urol Oncol. 2018 May;36(5):237.e19-237.e24 PMID: 29395954 02/06/2018

• National Surgical Quality Improvement Program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversion.

  (Golan S, Adamsky MA, Johnson SC, Barashi NS, Smith ZL, Rodriguez MV, Liao C, Smith ND, Steinberg GD, Shalhav AL.) Urol Oncol. 2018 02;36(2):77.e1-77.e7 PMID: 29033195 10/17/2017